Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome

Journal of Experimental Medicine

Volumn 211, Issue 3, 2014, Pages 499-513

  Furio, Laetitia ^a,b   De Veer, Simon ^a,b   Jaillet, Madeleine ^a,b   Briot, Anais ^b   Robin, Aurelie ^b   Deraison, Celine ^b   Hovnanian, Alain ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b IMAGINE INSTITUTE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; ELASTASE II; IMMUNOGLOBULIN E; KALLIKREIN 14; KALLIKREIN 5; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NETHERTON DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PRURITUS; STRATUM CORNEUM; T LYMPHOCYTE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; KALLIKREINS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NETHERTON SYNDROME; REAL-TIME POLYMERASE CHAIN REACTION; SKIN; STATISTICS, NONPARAMETRIC; WATER LOSS, INSENSIBLE;

EID: 84896899981     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131797     Document Type: Article

References (54)

1. Bennett, K., R. Callard, W. Heywood, J. Harper, A. Jayakumar, G.L. Clayman, W.L. Di, and K. Mills. 2010. New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J. Proteome Res. 9:4289-4294. http://dx.doi.org/10.1021/pr1003467
2. Bitoun, E., A. Micheloni, L. Lamant, C. Bonnart, A. Tartaglia-Polcini, C. Cobbold, T. Al Saati, F. Mariotti, J. Mazereeuw-Hautier, F. Boralevi, et al. 2003. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum. Mol. Genet. 12:2417-2430. http://dx.doi.org/10.1093/hmg/ddg247
3. Boniface, K., F.X. Bernard, M. Garcia, A.L. Gurney, J.C. Lecron, and F. Morel. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174:3695-3702.
4. Bonnart, C., C. Deraison, M. Lacroix, Y. Uchida, C. Besson, A. Robin, A. Briot, M. Gonthier, L. Lamant, P. Dubus, et al. 2010. Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J. Clin. Invest. 120:871-882. http://dx.doi.org/10.1172/JCI41440
5. Brattsand, M., and T. Egelrud. 1999. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274:30033-30040. http://dx.doi.org/10.1074/jbc.274.42.30033
6. Brattsand, M., K. Stefansson, C. Lundh, Y. Haasum, and T. Egelrud. 2005. A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124:198-203. http://dx.doi.org/10.1111/j.0022-202X.2004.23547.x
7. Briot, A., C. Deraison, M. Lacroix, C. Bonnart, A. Robin, C. Besson, P. Dubus, and A. Hovnanian. 2009. Kallikrein 5 induces atopic dermatitis- like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J. Exp. Med. 206:1135-1147. http://dx.doi.org/10.1084/jem.20082242
8. Carroll, J.M., and L.B. Taichman. 1992. Characterization of the human involucrin promoter using a transient beta-galactosidase assay. J. Cell Sci. 103:925-930.
9. Carroll, J.M., K.M. Albers, J.A. Garlick, R. Harrington, and L.B. Taichman. 1993. Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc. Natl. Acad. Sci. USA. 90:10270-10274. http://dx.doi.org/10.1073/pnas.90.21.10270
10. Caubet, C., N. Jonca, M. Brattsand, M. Guerrin, D. Bernard, R. Schmidt, T. Egelrud, M. Simon, and G. Serre. 2004. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/ KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122:1235-1244. http://dx.doi.org/10.1111/j.0022-202X.2004.22512.x
11. Chavanas SCT S., C. Bodemer, A. Rochat, D. Hamel-Teillac, M. Ali, A.D. Irvine, J.L. Bonafé, J. Wilkinson, A. Taïeb, Y. Barrandon, et al. 2000. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet. 25:141-142. http://dx.doi.org/10.1038/75977 Comel, M. 1949. Ichthyosis Linearis circumflexa. Dermatologica. 98:133-136. http://dx.doi.org/10.1159/00025729
12. Comel, M. 1949. Ichthyosis Linearis circumflexa. Dermatologica. 98:133-136. http://dx.doi.org/10.1159/000257290
13. de Veer, S.J., J.E. Swedberg, E.A. Parker, and J.M. Harris. 2012. Noncombinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14. Biol. Chem. 393:331-341. http://dx.doi.org/10.1515/bc-2011-250
14. de Veer, S.J., S.S. Ukolova, C.A. Munro, J.E. Swedberg, A.M. Buckle, and J.M. Harris. 2013. Mechanism-based selection of a potent kallikrein-related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI-1. Biopolymers. 100:510-518.
15. Denecker, G., E. Hoste, B. Gilbert, T. Hochepied, P. Ovaere, S. Lippens, C. Van den Broecke, P. Van Damme, K. D'Herde, J.P. Hachem, et al. 2007. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat. Cell Biol. 9:666-674. http://dx.doi.org/10.1038/ncb1597
16. Deraison, C., C. Bonnart, F. Lopez, C. Besson, R. Robinson, A. Jayakumar, F. Wagberg, M. Brattsand, J.P. Hachem, G. Leonardsson, and A. Hovnanian. 2007. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol. Biol. Cell. 18:3607-3619. http://dx.doi.org/10.1091/mbc.E07-02-0124
17. Descargues, P., C. Deraison, C. Bonnart, M. Kreft, M. Kishibe, A. Ishida- Yamamoto, P. Elias, Y. Barrandon, G. Zambruno, A. Sonnenberg, and A. Hovnanian. 2005. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat. Genet. 37:56-65.
18. Descargues, P., C. Deraison, C. Prost, S. Fraitag, J. Mazereeuw-Hautier, M. D'Alessio, A. Ishida-Yamamoto, C. Bodemer, G. Zambruno, and A. Hovnanian. 2006. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. J. Invest. Dermatol. 126:1622-1632. http://dx.doi.org/10.1038/sj.jid.5700284
19. Ekholm, I.E., M. Brattsand, and T. Egelrud. 2000. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J. Invest. Dermatol. 114:56-63. http://dx.doi.org/10.1046/j.1523-1747.2000.00820.x
20. Fortugno, P., A. Bresciani, C. Paolini, C. Pazzagli, M. El Hachem, M. D'Alessio, and G. Zambruno. 2011. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis. J. Invest. Dermatol. 131:2223-2232. http://dx.doi.org/10.1038/jid.2011.174
21. Frateschi, S., E. Camerer, G. Crisante, S. Rieser, M. Membrez, R.P. Charles, F. Beermann, J.C. Stehle, B. Breiden, K. Sandhoff, et al. 2011. PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin. Nat Commun. 2:161. http://dx.doi.org/10.1038/ncomms1162
22. Guttman-Yassky, E., N. Dhingra, and D.Y. Leung. 2013. New era of biologic therapeutics in atopic dermatitis. Expert Opin. Biol. Ther. 13:549- 561. http://dx.doi.org/10.1517/14712598.2013.758708
23. Hansson, L., A. Bäckman, A. Ny, M. Edlund, E. Ekholm, B. Ekstrand Hammarström, J. Törnell, P. Wallbrandt, H. Wennbo, and T. Egelrud. 2002. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J. Invest. Dermatol. 118:444-449. http://dx.doi.org/10.1046/j.0022-202x.2001.01684.x
24. Hausser, I., and I. Anton-Lamprecht. 1996. Severe congenital generalized exfoliative erythroderma in newborns and infants: a possible sign of Netherton syndrome. Pediatr. Dermatol. 13:183-199. http://dx.doi.org/10.1111/j.1525-1470.1996.tb01202.x
25. Hewett, D.R., A.L. Simons, N.E. Mangan, H.E. Jolin, S.M. Green, P.G. Fallon, and A.N. McKenzie. 2005. Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum. Mol. Genet. 14:335-346. http://dx.doi.org/10.1093/hmg/ddi030
26. Homey, B., and A. Zlotnik. 1999. Chemokines in allergy. Curr. Opin. Immunol. 11:626-634. http://dx.doi.org/10.1016/S0952-7915(99)00028-X
27. Horikawa, T., T. Nakayama, I. Hikita, H. Yamada, R. Fujisawa, T. Bito, S. Harada, A. Fukunaga, D. Chantry, P.W. Gray, et al. 2002. IFN- γ-inducible expression of thymus and activation-regulated chemokine/ CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int. Immunol. 14:767- 773. http://dx.doi.org/10.1093/intimm/dxf044
28. Hoste, E., P. Kemperman, M. Devos, G. Denecker, S. Kezic, N. Yau, B. Gilbert, S. Lippens, P. De Groote, R. Roelandt, et al. 2011. Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J. Invest. Dermatol. 131:2233-2241. http://dx.doi.org/10.1038/jid.2011.153
29. Hovnanian, A. 2013. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res. 351:289-300. http://dx.doi.org/10.1007/s00441-013-1558-1
30. Judge, M.R., G. Morgan, and J.I. Harper. 1994. A clinical and immunological study of Netherton's syndrome. Br. J. Dermatol. 131:615-621. http://dx.doi.org/10.1111/j.1365-2133.1994.tb04971.x
31. Kennedy-Crispin, M., E. Billick, H. Mitsui, N. Gulati, H. Fujita, P. Gilleaudeau, M. Sullivan-Whalen, L.M. Johnson-Huang, M. Suárez-Fariñas, and J.G. Krueger. 2012. Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity. J. Invest. Dermatol. 132:105-113. http://dx.doi.org/10.1038/jid.2011.262
32. Komatsu, N., K. Saijoh, N. Otsuki, T. Kishi, I.P. Micheal, C.V. Obiezu, C.A. Borgono, K. Takehara, A. Jayakumar, H.K. Wu, et al. 2007. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein. Clin. Chim. Acta. 377:228-236. http://dx.doi.org/10.1016/j.cca.2006.10.009
33. Lee, E.B., K.W. Kim, J.Y. Hong, H.M. Jee, M.H. Sohn, and K.E. Kim. 2010. Increased serum thymic stromal lymphopoietin in children with atopic dermatitis. Pediatr. Allergy Immunol. 21:e457-e460. http://dx.doi.org/10.1111/j.1399-3038.2009.00919.x
34. List, K., C.C. Haudenschild, R. Szabo, W. Chen, S.M. Wahl, W. Swaim, L.H. Engelholm, N. Behrendt, and T.H. Bugge. 2002. Matriptase/MTSP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene. 21:3765-3779. http://dx.doi.org/10.1038/sj.onc.1205502
35. Mills, K.H., L.S. Dungan, S.A. Jones, and J. Harris. 2013. The role of inflammasomederived IL-1 in driving IL-17 responses. J. Leukoc. Biol. 93:489-497. http://dx.doi.org/10.1189/jlb.1012543
36. Netherton, E.W. 1958. A unique case of trichorrhexis nodosa; bamboo hairs. AMA Arch. Derm. 78:483-487. http://dx.doi.org/10.1001/archderm.1958.01560100059009
37. Nograles, K.E., L.C. Zaba, E. Guttman-Yassky, J. Fuentes-Duculan, M. Suárez-Fariñas, I. Cardinale, A. Khatcherian, J. Gonzalez, K.C. Pierson, T.R. White, et al. 2008. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159:1092-1102.
38. Oji, V., G. Beljan, K. Beier, H. Traupe, and T.A. Luger. 2005. Topical pimecrolimus: a novel therapeutic option for Netherton syndrome. Br. J. Dermatol. 153:1067-1068. http://dx.doi.org/10.1111/j.1365-2133.2005.06884.x
39. Perera, G.K., P. Di Meglio, and F.O. Nestle. 2012. Psoriasis. Annu. Rev. Pathol. 7:385-422. http://dx.doi.org/10.1146/annurev-pathol-011811-132448
40. Renner, E.D., D. Hartl, S. Rylaarsdam, M.L. Young, L. Monaco-Shawver, G. Kleiner, M.L. Markert, E.R. Stiehm, B.H. Belohradsky, M.P. Upton, et al. 2009. Comél-Netherton syndrome defined as primary immunodeficiency. J. Allergy Clin. Immunol. 124:536-543. http://dx.doi.org/10.1016/j.jaci.2009.06.009
41. Roth, W., J. Deussing, V.A. Botchkarev, M. Pauly-Evers, P. Saftig, A. Hafner, P. Schmidt, W. Schmahl, J. Scherer, I. Anton-Lamprecht, et al. 2000. Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J. 14:2075-2086. http://dx.doi.org/10.1096/fj.99-0970com
42. Sakabe, J., M. Yamamoto, S. Hirakawa, A. Motoyama, I. Ohta, K. Tatsuno, T. Ito, K. Kabashima, T. Hibino, and Y. Tokura. 2013. Kallikreinrelated peptidase 5 functions in proteolytic processing of profilaggrin in cultured human keratinocytes. J. Biol. Chem. 288:17179-17189. http://dx.doi.org/10.1074/jbc.M113.476820
43. Sales, K.U., A. Masedunskas, A.L. Bey, A.L. Rasmussen, R. Weigert, K. List, R. Szabo, P.A. Overbeek, and T.H. Bugge. 2010. Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome. Nat. Genet. 42:676-683. http://dx.doi.org/10.1038/ng.629
44. Soumelis, V., P.A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673-680. http://dx.doi.org/10.1038/nrm910
45. Stefansson, K., M. Brattsand, A. Ny, B. Glas, and T. Egelrud. 2006. Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol. Chem. 387:761-768. http://dx.doi.org/10.1515/BC.2006.095
46. Stefansson, K., M. Brattsand, D. Roosterman, C. Kempkes, G. Bocheva, M. Steinhoff, and T. Egelrud. 2008. Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J. Invest. Dermatol. 128:18-25. http://dx.doi.org/10.1038/sj.jid.5700965
47. Steinhoff, M., U. Neisius, A. Ikoma, M. Fartasch, G. Heyer, P.S. Skov, T.A. Luger, and M. Schmelz. 2003. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci. 23:6176-6180.
48. Stryk, S., E.C. Siegfried, and A.P. Knutsen. 1999. Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome. Pediatr. Dermatol. 16:19-22. http://dx.doi.org/10.1046/j.1525-1470.1999.99005.x
49. Suárez-Fariñas, M., N. Dhingra, J. Gittler, A. Shemer, I. Cardinale, C. de Guzman Strong, J.G. Krueger, and E. Guttman-Yassky. 2013. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J. Allergy Clin. Immunol. 132:361-370. http://dx.doi.org/10.1016/j.jaci.2013.04.046
50. Sun, J.D., and K.G. Linden. 2006. Netherton syndrome: a case report and review of the literature. Int. J. Dermatol. 45:693-697. http://dx.doi.org/10.1111/j.1365-4632.2005.02637.x
51. Suzuki, Y., J. Nomura, J. Hori, J. Koyama, M. Takahashi, and I. Horii. 1993. Detection and characterization of endogenous protease associated with desquamation of stratum corneum. Arch. Dermatol. Res. 285:372- 377. http://dx.doi.org/10.1007/BF00371839
52. Tsuda, T., M. Tohyama, K. Yamasaki, Y. Shirakata, Y. Yahata, S. Tokumaru, K. Sayama, and K. Hashimoto. 2003. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J. Dermatol. Sci. 31:37-42. http://dx.doi.org/10.1016/S0923-1811(02)00138-X
53. Yamasaki, K., J. Schauber, A. Coda, H. Lin, R.A. Dorschner, N.M. Schechter, C. Bonnart, P. Descargues, A. Hovnanian, and R.L. Gallo. 2006. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20:2068-2080. http://dx.doi.org/10.1096/fj.06-6075com
54. -/- mice. Genes Dev. 18:2354-2358. http://dx.doi.org/10.1101/gad.1232104